Salud
Madrid pioneers the fight against ALS with an innovative clinical trial
Madrid launches an innovative clinical trial with the drug AP-2 to treat Amyotrophic Lateral Sclerosis (ALS), marking a milestone in medical research.
Ensayo clínico
Latest Ensayo clínico news
2 articles
Salud
A new drug could change the fate of ALS patients in Madrid
An innovative drug called AP-2 begins clinical trials in Madrid, offering new hope to patients with amyotrophic lateral sclerosis.